Group 1 - The company Sichuan Road and Bridge (600039.SH) announced its first share buyback on September 12, 2025, through centralized bidding, repurchasing 476,000 shares, which represents 0.0055% of the company's total share capital [1] - The highest transaction price for the repurchased shares was 8.76 CNY per share, while the lowest was 8.70 CNY per share [1] - The total amount paid for the share buyback was 4,155,160 CNY, excluding transaction fees [1]

Group 1 - The company Sichuan Road and Bridge (600039.SH) announced its first share buyback on September 12, 2025, through centralized bidding, repurchasing 476,000 shares, which represents 0.0055% of the company's total share capital [1] - The highest transaction price for the repurchased shares was 8.76 CNY per share, while the lowest was 8.70 CNY per share [1] - The total amount paid for the share buyback was 4,155,160 CNY, excluding transaction fees [1]

Group 1 - Sichuan Road and Bridge's controlling shareholder plans to reduce its stake by up to 2% of the company's total shares, amounting to approximately 174 million shares [1] - Jinlongyu's shareholder terminates the share transfer agreement, halting the planned transfer of 5.32% of the company's shares [1] - Doli Technology's subsidiary plans to establish a joint venture in Spain with an investment of approximately 505 million yuan, with a 70% stake held by Doli Technology [1][2] Group 2 - Chongqing Pharmaceutical, a subsidiary of Zhongyao Holdings, has received approval for clinical trials of its drug, Clopidogrel Hydrochloride Tablets [3][4] - Dongyangguang plans to jointly increase capital in a subsidiary to acquire 100% of Qinhuai Data China for 28 billion yuan [5] - Kangzhi Pharmaceutical's controlling shareholder intends to transfer 5.0004% of the company's shares at a price of 5.34 yuan per share, totaling approximately 122 million yuan [6] Group 3 - Huali Co., Ltd. announces two shareholders plan to reduce their stakes by a combined total of up to 3.96% of the company's shares [7] - Fangbang Co., Ltd.'s director plans to reduce his stake by up to 15,000 shares, representing 0.1844% of the total shares [8] - China Pacific Insurance suggests issuing HKD-denominated convertible bonds, with proceeds aimed at supporting its main insurance business and strategic initiatives [9] Group 4 - Microchip Biotech's shareholder plans to reduce its stake by up to 3% of the company's total shares [10] - Hongbai New Materials' controlling shareholder intends to reduce its stake by up to 3% due to funding needs [11] - Zhejiang Rongtai clarifies that its sales in the robotics components sector are minimal and will not significantly impact annual net profit [12] Group 5 - ST Tianmao voluntarily withdraws its application for A-share listing, which has been accepted by the Shenzhen Stock Exchange [13] - Qingxin Environment's shareholder plans to reduce its stake by up to 1% of the company's total shares [14] - Lanjik Technology's two shareholders plan to reduce their stakes by a combined total of up to 2% of the company's shares [15] Group 6 - BYD's executives and core personnel collectively increased their holdings in the company by approximately 52.33 million yuan [16] - Trina Solar's subsidiary signs contracts for the sale of 2.48 GWh of energy storage products, marking a significant overseas order [17] - Chutianlong's shareholder plans to reduce its stake by up to 3% of the company's total shares [18] Group 7 - Zhongjuxin's shareholder plans to reduce its stake by up to 2.5% of the company's total shares due to funding needs [19] - ST Hezhong's controlling shareholder is under bail pending trial, but company operations remain unaffected [20] - Shoukai Co., Ltd. reports a signed contract amount of 973 million yuan for August, with cumulative contracts of 13.15 billion yuan for the year [21] Group 8 - Jucheng Co., Ltd.'s shareholder plans to reduce its stake by up to 2.61% of the company's total shares due to personal funding needs [22]

Core Viewpoint - Sichuan Road and Bridge experienced a decline in stock price and net outflow of funds, while its year-to-date performance shows a significant increase despite recent fluctuations [1][2]. Financial Performance - As of June 30, 2025, Sichuan Road and Bridge reported a revenue of 43.54 billion yuan, a year-on-year decrease of 4.91%, and a net profit attributable to shareholders of 2.78 billion yuan, down 13.00% compared to the previous year [2]. - Cumulative cash dividends since the company's A-share listing amount to 18.58 billion yuan, with 13.78 billion yuan distributed over the last three years [3]. Stock Market Activity - On September 11, the stock price fell by 2.04% to 8.63 yuan per share, with a trading volume of 85.11 million yuan and a turnover rate of 0.15%, resulting in a total market capitalization of 75.04 billion yuan [1]. - The stock has increased by 25.02% year-to-date, but has seen a decline of 1.48% over the last five trading days and an 8.80% drop over the last 60 days [1]. Shareholder Information - The number of shareholders decreased by 23.90% to 50,400, while the average circulating shares per person increased by 31.41% to 133,066 shares [2]. - Major shareholders include Hong Kong Central Clearing Limited, which increased its holdings by 25.44 million shares, and other significant shareholders also increased their positions [3]. Business Overview - Sichuan Road and Bridge, established on December 28, 1999, and listed on March 25, 2003, primarily engages in infrastructure construction and investment operations, with engineering construction accounting for 89.20% of its revenue [1]. - The company operates in the construction and decoration sector, specifically in municipal engineering [1].

证券代码：600039 证券简称：四川路桥 公告编号：2025-099 四川路桥建设集团股份有限公司 控股股东通过大宗交易减持公司股份计划公告 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏， 并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： ● 控股股东及其一致行动人持股的基本情况：四川路桥建设集团股份有限公司（以下简称公司或四川路 桥）控股股东蜀道投资集团有限责任公司（以下简称蜀道集团）持有公司4,950,301,259股股份，占公司 总股本的比例为56.93%，蜀道集团及其一致行动人四川高速公路建设开发集团有限公司（以下简称川 高公司）、四川藏区高速公路有限责任公司（以下简称藏高公司）、蜀道资本控股集团有限公司（以下 简称蜀道资本）、四川高路文化旅游发展有限责任公司（以下简称高路文旅）共持有公司6,927,708,854 股股份，占公司总股本的比例为79.67%。 ● 减持计划的主要内容：为引入认可公司内在价值和看好未来发展的价值投资者、优化公司股权结构， 蜀道集团计划通过大宗交易方式减持公司股份不超过173,911,812股，即不超过公司总股本 ...

Mergers and Acquisitions - Dongyangguang plans to jointly increase capital in Yichang Dongshu No.1 Investment Co., Ltd. with an associated party, with capital increases of 3.5 billion and 4 billion yuan respectively. The company intends to acquire 100% equity of Qinhuai Data's China operations through its wholly-owned subsidiary [1] - Aimeike has completed the acquisition of controlling interest in South Korea's REGEN Biotech, Inc., obtaining 59.5% equity after the completion of the transaction [2] - Longzi Co., Ltd. plans to acquire 67.5% equity of Chongqing Time through a cash payment of 92.475 million yuan [3] Shareholding Changes - Hongbai New Materials' controlling shareholder plans to reduce its stake by up to 3%, which includes a maximum of 6.5 million shares through centralized bidding and 13 million shares through block trading [4] - BYD executives and core personnel collectively increased their holdings by 488,200 shares, with a total investment of 52.3278 million yuan [5] - Sichuan Road and Bridge's controlling shareholder intends to reduce its stake by up to 2%, equating to a maximum of 17.4 million shares [6] Regulatory Issues - Baiyin Nonferrous Metals has received a notice from the China Securities Regulatory Commission regarding an investigation for suspected violations of information disclosure [7] - Huangting International's wholly-owned subsidiary's asset, the Crystal Island International Shopping Center, was put up for auction but ultimately failed to sell [8]

每经记者｜王琳 每经编辑｜魏官红 并购重组 东阳光：拟与关联方收购秦淮数据中国100%股权 东阳光公告，公司与关联方深圳市东阳光实业发展有限公司拟共同增资宜昌东数一号投资有限责任公 司，增资金额分别为35亿元、40亿元。同时，东数一号拟通过全资孙公司宜昌东数三号投资有限责任公 司收购秦淮数据中国区业务经营主体100%股权。 爱美客：收购韩国REGEN控股权交割完成 爱美客公告，公司方面已完成收购韩国REGEN Biotech,Inc.公司（以下简称韩国REGEN）控股权的交 割。爱美客国际已取得韩国相关部门颁发的大法院登记证明和外国投资者登记证明。公司持有爱美客国 际70％股权，本次交割完成后，爱美客国际持有韩国REGEN 85％股权，公司进而实际取得韩国REGEN 59.5％股权。 朗姿股份：拟收购重庆时光67.5%股权 朗姿股份公告，公司全资子公司北京朗姿医疗管理有限公司拟以9247.50万元现金收购重庆米兰柏羽时 光整形美容医院有限公司67.50%的控股权。 增减持 宏柏新材：控股股东拟减持不超3%公司股份 宏柏新材公告，控股股东宏柏化学有限公司拟通过集中竞价交易的方式减持不超过650万股公司股份， 占 ...

Group 1 - Tianpu Co., Ltd. experienced a significant stock price increase of 185.29% from August 22 to September 10, leading to a halt for further investigation due to abnormal trading [4] - Baiyin Nonferrous Metals has been investigated by the China Securities Regulatory Commission for suspected violations of information disclosure [5] - Qingshan Paper Industry confirmed that its production and operational activities are normal, with no significant changes in daily operations [6] Group 2 - Aoyang Health announced that its stock will continue to be suspended due to ongoing negotiations regarding a share transfer by its controlling shareholder [7] - ST Jinke will implement a capital reserve transfer to increase share capital, resulting in a one-day stock suspension [8] - ST Haofeng's stock will resume trading on September 11 after a share transfer agreement was signed, making Zhixin Network the controlling shareholder [9] Group 3 - Fushun Special Steel's stock will be suspended for one day due to a tender offer for shares by Ningbo Meishan Free Trade Port Zone Jincheng Shazhou Equity Investment Co., Ltd. [10] - Fuliwang's subsidiary plans to invest 500 million yuan in a high-end wire material research and production project [11] - ST Tianmao's application for voluntary delisting has been accepted by the Shenzhen Stock Exchange [12] Group 4 - Dongyangguang plans to jointly increase capital in a subsidiary for the acquisition of Qinhuai Data China [13] - Betta Pharmaceuticals intends to issue H-shares and apply for listing on the Hong Kong Stock Exchange [14] - Longzi Co., Ltd. plans to acquire a 67.5% stake in Chongqing Time for approximately 92.475 million yuan [15] Group 5 - Dongfang Guoxin plans to establish a joint venture for a technology company with Shunyi Jin Kong [16] - ST Lianshi signed a pre-restructuring investment agreement with selected investors [18] - Shaanxi Construction Group won four construction projects worth over 5 billion yuan in August [19] Group 6 - Dema Technology won a smart logistics project with a well-known Latin American e-commerce giant, valued at approximately 290 million yuan [20] - Mongolian Grass Ecology's subsidiary led a consortium to win a 225 million yuan ecological restoration project [21] - Dajin Heavy Industry signed a long-term production agreement for offshore wind power foundations, with a total value of about 1.25 billion yuan [24] Group 7 - Zhendong Medical's controlling shareholder plans to transfer 5% of the company's shares [25] - ST Hezhong's controlling shareholder is under bail pending trial, but company operations remain unaffected [26] - BYD's senior management and core personnel collectively increased their holdings by approximately 52.33 million yuan [27] Group 8 - Jiahe Meikang's shareholder plans to reduce its stake by up to 1.94% [28] - Sichuan Road and Bridge's controlling shareholder plans to reduce its stake by up to 2% [30] - Lanke Technology's shareholders plan to reduce their holdings by up to 2% [31]

Group 1 - Hualing Steel's shareholder, Xintai Life, has recently increased its stake by 69.0862 million shares and plans to continue increasing its holdings by 1% to 2% [1] - Jingfang Technology's shareholder has terminated its share reduction plan ahead of schedule, with no shares sold during the period [1] - Huali Co., Ltd. plans to reduce its holdings by no more than 3.96% of the company's shares [1] Group 2 - Various companies, including Wuchan Jinlun, Changhua Chemical, COFCO Technology, and Jieshun Technology, have announced plans to reduce their holdings by no more than 3% of their shares [1] - Other companies such as Micron Biotech, Hongbai New Materials, and Jucheng Technology have also indicated plans to reduce their stakes by varying percentages, mostly around 2% to 3% [1] - Specific reductions include 2.61% by Jucheng Co., 2.5% by Zhongju Xinxin, and 1.94% by Jiahe Meikang [1]

Group 1 - Sichuan Road and Bridge (600039) announced that its controlling shareholder, Shudao Investment Group, plans to reduce its stake by up to 2% of the total share capital through block trading from October 13, 2025, to December 31, 2025 [1] - As of now, Shudao Group holds 56.93% of Sichuan Road and Bridge's total share capital, with diverse sources of shares including 422 million shares obtained before the IPO and 1.398 billion shares acquired through asset purchases [1] - Shudao Group has four concerted actors, collectively holding 22.74% of the total share capital, resulting in a combined ownership of 79.67% by Shudao Group and its concerted actors [1] Group 2 - Sichuan Road and Bridge has shown strong stock performance recently, with a market capitalization of 76.6 billion yuan [2] - Shudao Group, a large provincial state-owned enterprise with total assets of 1.5 trillion yuan, owns five listed companies including Sichuan Road and Bridge and has stakes in two other listed companies [2] - In July, Shudao Group planned to subscribe to a capital increase in Hongda Co., holding 31.31% of the total share capital before the acquisition, which will increase to 47.17% post-acquisition [2]